New Risk • Apr 24
New major risk - Revenue and earnings growth Earnings have declined by 6.7% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.7% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (8.3% average weekly change). New Risk • Apr 20
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company. Reported Earnings • Apr 17
Full year 2025 earnings released: CN¥0.30 loss per share (vs CN¥0.043 profit in FY 2024) Full year 2025 results: CN¥0.30 loss per share (down from CN¥0.043 profit in FY 2024). Revenue: CN¥2.62b (down 4.2% from FY 2024). Net loss: CN¥255.0m (down CN¥290.6m from profit in FY 2024). Over the last 3 years on average, earnings per share has fallen by 35% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings. Announcement • Apr 17
Beijing Water Business Doctor Co., Ltd., Annual General Meeting, May 08, 2026 Beijing Water Business Doctor Co., Ltd., Annual General Meeting, May 08, 2026, at 15:00 China Standard Time. Location: 4F, Building 22, Yard No. 1, Wuliqiao 1st Street, Chaoyang District, Beijing China Announcement • Mar 31
Beijing Water Business Doctor Co., Ltd. to Report Q1, 2026 Results on Apr 24, 2026 Beijing Water Business Doctor Co., Ltd. announced that they will report Q1, 2026 results on Apr 24, 2026 Announcement • Dec 31
Beijing Water Business Doctor Co., Ltd. to Report Fiscal Year 2025 Results on Apr 17, 2026 Beijing Water Business Doctor Co., Ltd. announced that they will report fiscal year 2025 results on Apr 17, 2026 Reported Earnings • Oct 30
Third quarter 2025 earnings released: EPS: CN¥0.003 (vs CN¥0.021 loss in 3Q 2024) Third quarter 2025 results: EPS: CN¥0.003 (up from CN¥0.021 loss in 3Q 2024). Revenue: CN¥597.5m (down 5.4% from 3Q 2024). Net income: CN¥2.49m (up CN¥19.9m from 3Q 2024). Profit margin: 0.4% (up from net loss in 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 6% per year, which means it has not declined as severely as earnings. Announcement • Sep 30
Beijing Water Business Doctor Co., Ltd. to Report Q3, 2025 Results on Oct 30, 2025 Beijing Water Business Doctor Co., Ltd. announced that they will report Q3, 2025 results on Oct 30, 2025 Declared Dividend • Jul 06
Dividend of CN¥0.015 announced Shareholders will receive a dividend of CN¥0.015. Ex-date: 8th July 2025 Payment date: 8th July 2025 Dividend yield will be 0.3%, which is lower than the industry average of 3.1%. Sustainability & Growth Dividend is covered by earnings (41% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has decreased over the past 10 years, indicating a lack of growth and stability in payments. The company's earnings per share (EPS) would need to decline by 54% to shift the payout ratio to a potentially unsustainable range, which is more than the 5.9% EPS decline seen over the last 5 years. Announcement • Jul 02
Beijing Water Business Doctor Co., Ltd. to Report First Half, 2025 Results on Aug 27, 2025 Beijing Water Business Doctor Co., Ltd. announced that they will report first half, 2025 results on Aug 27, 2025 New Risk • Apr 23
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 210% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.7% per year over the past 5 years. Minor Risk Large one-off items impacting financial results. Reported Earnings • Apr 19
Full year 2024 earnings released: EPS: CN¥0.043 (vs CN¥0.23 loss in FY 2023) Full year 2024 results: EPS: CN¥0.043 (up from CN¥0.23 loss in FY 2023). Revenue: CN¥2.73b (down 3.2% from FY 2023). Net income: CN¥35.6m (up CN¥226.8m from FY 2023). Profit margin: 1.3% (up from net loss in FY 2023). The move to profitability was driven by lower expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 79 percentage points per year, which is a significant difference in performance. Announcement • Apr 19
Beijing Water Business Doctor Co., Ltd. Proposes Final Dividend for 2024 Beijing Water Business Doctor Co., Ltd. proposed final cash dividend of CNY 0.15000000 per 10 shares (tax included) for 2024. Announcement • Apr 18
Beijing Water Business Doctor Co., Ltd., Annual General Meeting, May 09, 2025 Beijing Water Business Doctor Co., Ltd., Annual General Meeting, May 09, 2025, at 15:00 China Standard Time. Location: 4F, Building 22, Yard No. 1, Wuliqiao 1st Street, Chaoyang District, Beijing China Announcement • Mar 31
Beijing Water Business Doctor Co., Ltd. to Report Q1, 2025 Results on Apr 28, 2025 Beijing Water Business Doctor Co., Ltd. announced that they will report Q1, 2025 results on Apr 28, 2025 Announcement • Dec 31
Beijing Water Business Doctor Co., Ltd. to Report Fiscal Year 2024 Results on Apr 18, 2025 Beijing Water Business Doctor Co., Ltd. announced that they will report fiscal year 2024 results on Apr 18, 2025 Reported Earnings • Oct 25
Third quarter 2024 earnings released: CN¥0.021 loss per share (vs CN¥0.004 profit in 3Q 2023) Third quarter 2024 results: CN¥0.021 loss per share (down from CN¥0.004 profit in 3Q 2023). Revenue: CN¥631.5m (down 11% from 3Q 2023). Net loss: CN¥17.4m (down CN¥20.6m from profit in 3Q 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 44 percentage points per year, which is a significant difference in performance. Announcement • Sep 30
Beijing Water Business Doctor Co., Ltd. to Report Q3, 2024 Results on Oct 25, 2024 Beijing Water Business Doctor Co., Ltd. announced that they will report Q3, 2024 results on Oct 25, 2024 Reported Earnings • Aug 28
Second quarter 2024 earnings released: CN¥0.002 loss per share (vs CN¥0.019 profit in 2Q 2023) Second quarter 2024 results: CN¥0.002 loss per share (down from CN¥0.019 profit in 2Q 2023). Revenue: CN¥552.3m (down 31% from 2Q 2023). Net loss: CN¥2.04m (down 113% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has fallen by 32% per year, which means it is performing significantly worse than earnings. Announcement • Jun 29
Beijing Water Business Doctor Co., Ltd. to Report First Half, 2024 Results on Aug 28, 2024 Beijing Water Business Doctor Co., Ltd. announced that they will report first half, 2024 results on Aug 28, 2024 Announcement • Apr 24
Beijing Water Business Doctor Co., Ltd., Annual General Meeting, May 15, 2024 Beijing Water Business Doctor Co., Ltd., Annual General Meeting, May 15, 2024, at 15:00 China Standard Time. Location: 4F, Building 22, Yard No. 1, Wuliqiao 1st Street, Chaoyang District, Beijing China Reported Earnings • Apr 24
Full year 2023 earnings released: CN¥0.23 loss per share (vs CN¥0.098 profit in FY 2022) Full year 2023 results: CN¥0.23 loss per share (down from CN¥0.098 profit in FY 2022). Revenue: CN¥2.82b (up 3.8% from FY 2022). Net loss: CN¥191.2m (down 344% from profit in FY 2022). Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has fallen by 14% per year, which means it is significantly lagging earnings. Announcement • Mar 30
Beijing Water Business Doctor Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024 Beijing Water Business Doctor Co., Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024 Announcement • Dec 30
Beijing Water Business Doctor Co., Ltd. to Report Fiscal Year 2023 Results on Apr 24, 2024 Beijing Water Business Doctor Co., Ltd. announced that they will report fiscal year 2023 results on Apr 24, 2024 Reported Earnings • Oct 25
Third quarter 2023 earnings released: EPS: CN¥0.004 (vs CN¥0.063 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.004 (down from CN¥0.063 in 3Q 2022). Revenue: CN¥707.0m (up 2.9% from 3Q 2022). Net income: CN¥3.23m (down 94% from 3Q 2022). Profit margin: 0.5% (down from 7.4% in 3Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 74% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings. Announcement • Sep 30
Beijing Water Business Doctor Co., Ltd. to Report Q3, 2023 Results on Oct 25, 2023 Beijing Water Business Doctor Co., Ltd. announced that they will report Q3, 2023 results on Oct 25, 2023 Reported Earnings • Aug 25
Second quarter 2023 earnings released: EPS: CN¥0.019 (vs CN¥0.032 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.019 (down from CN¥0.032 in 2Q 2022). Revenue: CN¥804.9m (up 43% from 2Q 2022). Net income: CN¥15.9m (down 39% from 2Q 2022). Profit margin: 2.0% (down from 4.6% in 2Q 2022). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has remained flat, which means it is significantly lagging earnings. Reported Earnings • Apr 25
Full year 2022 earnings released: EPS: CN¥0.098 (vs CN¥0.26 in FY 2021) Full year 2022 results: EPS: CN¥0.098 (down from CN¥0.26 in FY 2021). Revenue: CN¥2.72b (up 35% from FY 2021). Net income: CN¥78.4m (down 63% from FY 2021). Profit margin: 2.9% (down from 11% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 29% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Board Change • Nov 16
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 2 experienced directors. No highly experienced directors. Non-Employee Representative Supervisor Hui Zhang is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Oct 27
Third quarter 2022 earnings released: EPS: CN¥0.063 (vs CN¥0.066 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.063 (down from CN¥0.066 in 3Q 2021). Revenue: CN¥686.9m (up 20% from 3Q 2021). Net income: CN¥50.6m (down 11% from 3Q 2021). Profit margin: 7.4% (down from 9.9% in 3Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Reported Earnings • Aug 23
Second quarter 2022 earnings released: EPS: CN¥0.032 (vs CN¥0.051 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.032 (down from CN¥0.051 in 2Q 2021). Revenue: CN¥561.8m (up 16% from 2Q 2021). Net income: CN¥25.8m (down 42% from 2Q 2021). Profit margin: 4.6% (down from 9.1% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has only increased by 16% per year, which means it is significantly lagging earnings growth. Announcement • Jun 02
Beijing Water Business Doctor Co., Ltd. Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on 08 June 2022 Beijing Water Business Doctor Co., Ltd. announced final profit distribution plan to be implemented on A shares as cash dividend per ten shares (tax included) of CNY 0.30000000 for the year 2021, payable on 08 June 2022. Record date: 07 June 2022. Ex-date: 08 June 2022. Net cash dividend per ten shares after tax: CNY 0.27000000 (CNY 0.30000000 – CNY 0.03000000). Board Change • Jun 01
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 2 experienced directors. No highly experienced directors. Non-Employee Representative Supervisor Hui Zhang is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Board Change • May 02
High number of new and inexperienced directors There are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 2 experienced directors. No highly experienced directors. Non-Employee Representative Supervisor Hui Zhang is the most experienced director on the board, commencing their role in 2019. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors. Reported Earnings • Apr 28
First quarter 2022 earnings: EPS and revenues miss analyst expectations First quarter 2022 results: EPS: CN¥0.032 (down from CN¥0.14 in 1Q 2021). Revenue: CN¥651.1m (up 116% from 1Q 2021). Net income: CN¥25.9m (down 78% from 1Q 2021). Profit margin: 4.0% (down from 40% in 1Q 2021). The decrease in margin was driven by higher expenses. Revenue missed analyst estimates by 57%. Earnings per share (EPS) also missed analyst estimates by 122%. Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Reported Earnings • Oct 27
Third quarter 2021 earnings released: EPS CN¥0.066 (vs CN¥0.031 in 3Q 2020) The company reported a solid third quarter result with improved earnings and revenues, although profit margins were weaker. Third quarter 2021 results: Revenue: CN¥574.8m (up 284% from 3Q 2020). Net income: CN¥56.8m (up 114% from 3Q 2020). Profit margin: 9.9% (down from 18% in 3Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has fallen by 62% per year but the company’s share price has increased by 15% per year, which means it is well ahead of earnings. Reported Earnings • Aug 23
Second quarter 2021 earnings released: EPS CN¥0.051 (vs CN¥0.036 in 2Q 2020) The company reported a solid second quarter result with improved earnings and revenues, although profit margins were weaker. Second quarter 2021 results: Revenue: CN¥486.3m (up 179% from 2Q 2020). Net income: CN¥44.3m (up 41% from 2Q 2020). Profit margin: 9.1% (down from 18% in 2Q 2020). The decrease in margin was driven by higher expenses. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 82 percentage points per year, which is a significant difference in performance. Announcement • May 22
Beijing Water Business Doctor Co., Ltd. Approves Final Dividend for the Year 2020 Beijing Water Business Doctor Co., Ltd. announced at the AGM held on 20, 2021 that the company approved final dividend of CNY 0.150 per 10 shares (tax included) for the year 2020. Reported Earnings • May 01
First quarter 2021 earnings released: EPS CN¥0.14 (vs CN¥0.041 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥301.4m (up 213% from 1Q 2020). Net income: CN¥120.1m (up 236% from 1Q 2020). Profit margin: 40% (up from 37% in 1Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 60 percentage points per year, which is a significant difference in performance. Announcement • Apr 29
Beijing Water Business Doctor Co., Ltd. Proposes Final Dividend for the Year 2020 Beijing Water Business Doctor Co., Ltd. proposed final dividend of CNY 0.150 per 10 shares (tax included) for the year 2020. Is New 90 Day High Low • Mar 10
New 90-day high: CN¥6.68 The company is up 4.0% from its price of CN¥6.43 on 10 December 2020. The Chinese market is down 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Water Utilities industry, which is down 5.0% over the same period. Is New 90 Day High Low • Jan 26
New 90-day low: CN¥5.22 The company is down 29% from its price of CN¥7.40 on 28 October 2020. The Chinese market is up 12% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is down 12% over the same period. Is New 90 Day High Low • Jan 06
New 90-day low: CN¥5.85 The company is down 19% from its price of CN¥7.25 on 30 September 2020. The Chinese market is up 11% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is down 5.0% over the same period. Is New 90 Day High Low • Dec 12
New 90-day low: CN¥6.26 The company is down 18% from its price of CN¥7.64 on 11 September 2020. The Chinese market is up 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is down 8.0% over the same period. Is New 90 Day High Low • Nov 26
New 90-day low: CN¥6.88 The company is down 9.0% from its price of CN¥7.59 on 28 August 2020. The Chinese market is down 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Water Utilities industry, which is down 6.0% over the same period. Announcement • Oct 20
Beijing Water Business Doctor Co., Ltd. to Report Q3, 2020 Results on Oct 28, 2020 Beijing Water Business Doctor Co., Ltd. announced that they will report Q3, 2020 results on Oct 28, 2020 Announcement • Jul 24
Beijing Water Business Doctor Co., Ltd. to Report First Half, 2020 Results on Aug 20, 2020 Beijing Water Business Doctor Co., Ltd. announced that they will report first half, 2020 results on Aug 20, 2020